Researchers Found Pancreatic Cancer Immune Shields
A September 9, 2026, study reveals how specific cancer cells form protective fibrin barriers.
Updated on Sept. 24, 2026 in Cancer
Live Poll
Are you confident that new cancer research breakthroughs will lead to better survival outcomes soon?
Researchers identified a subpopulation of pancreatic cancer cells that creates immune-suppressing fibrin barriers. These niches shield tumors by excluding cancer-killing T cells and recruiting immune-suppressing macrophages.
Why it matters
Cancer cells organize local environments to shield themselves and neighboring cells from the immune system, contributing to the poor outcomes associated with pancreatic ductal adenocarcinoma. Targeting this fibrin-macrophage pathway may provide a path toward more effective immunotherapy for patients.
A small population of 5 percent PAI1-producing cancer cells can protect an entire tumor. While pancreatic ductal adenocarcinoma has a five-year survival rate of about 13 percent, deleting PAI1 or PAI2 genes reduced tumor burden by more than half.
The players
Icahn School of Medicine at Mount Sinai
This institution served as the site where the pancreatic cancer research was conducted.
The details
The cancer cells use PAI1 and PAI2 proteins to interfere with enzymes that would otherwise break down fibrin, effectively building a fortress around the tumor. Using the Perturb-map spatial genomics platform, researchers observed that blocking these proteins increases the number of CD8 T cells within tumors.
Timeline
September 9, 2026: Study findings published in Nature.
The Big Picture
This discovery marks a departure from traditional oncology by highlighting how cancer cells use the Perturb-map spatial genomics platform to reorganize their immediate immune environment.
This research provides a new potential target for immunotherapy treatments that could eventually improve survival rates for pancreatic cancer. Patients should note that these findings are currently limited to mouse models and require further clinical investigation.
The takeaway
Understanding how cancer cells engineer their surroundings to exclude immune cells is a critical step in overcoming tumor resistance. Future therapies may eventually leverage this knowledge to strip away these defenses and restore the efficacy of the immune system.
Further reading
Learn more about the latest research in Cancer.
More information
Read the complete Nature study on pancreatic cancer to review the methodology and results.
Live Poll
Are you confident that new cancer research breakthroughs will lead to better survival outcomes soon?
